This gene encodes the human homolog of the proto-oncogene c-kit. C-kit was first identified as the cellular homolog of the feline sarcoma viral oncogene v-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myel... See more...

Aliases for KIT Gene

Aliases for KIT Gene

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase 2 3 5
  • V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog 2 3 4
  • Mast/Stem Cell Growth Factor Receptor Kit 2 3 4
  • Tyrosine-Protein Kinase Kit 3 4
  • Piebald Trait Protein 3 4
  • Proto-Oncogene C-Kit 3 4
  • EC 2.7.10.1 4 54
  • P145 C-Kit 3 4
  • SCFR 3 4
  • PBT 3 4
  • V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene-Like Protein 3
  • Proto-Oncogene Tyrosine-Protein Kinase Kit 3
  • Soluble KIT Variant 1 3
  • C-Kit Protooncogene 3
  • CD117 Antigen 4
  • Piebald Trait 2
  • EC 2.7.10 54
  • C-Kit 3
  • CD117 3
  • MASTC 3

External Ids for KIT Gene

Previous HGNC Symbols for KIT Gene

  • PBT

Previous GeneCards Identifiers for KIT Gene

  • GC04P055328
  • GC04P055485
  • GC04P055439
  • GC04P055365
  • GC04P055218
  • GC04P051471
  • GC04P055524

Summaries for KIT Gene

Entrez Gene Summary for KIT Gene

  • This gene encodes the human homolog of the proto-oncogene c-kit. C-kit was first identified as the cellular homolog of the feline sarcoma viral oncogene v-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous lukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

CIViC Summary for KIT Gene

  • c-KIT activation has been shown to have oncogenic activity in gastrointestinal stromal tumors (GISTs), melanomas, lung cancer, and other tumor types. The targeted therapeutics nilotinib and sunitinib have shown efficacy in treating KIT overactive patients, and are in late-stage trials in melanoma and GIST. KIT overactivity can be the result of many genomic events from genomic amplification to overexpression to missense mutations. Missense mutations have been shown to be key players in mediating clinical response and acquired resistance in patients being treated with these targeted therapeutics.

GeneCards Summary for KIT Gene

KIT (KIT Proto-Oncogene, Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with KIT include Piebald Trait and Gastrointestinal Stromal Tumor. Among its related pathways are PI3K/AKT activation and RET signaling. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and protein kinase activity. An important paralog of this gene is CSF1R.

UniProtKB/Swiss-Prot Summary for KIT Gene

  • Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. In response to KITLG/SCF binding, KIT can activate several signaling pathways. Phosphorylates PIK3R1, PLCG1, SH2B2/APS and CBL. Activates the AKT1 signaling pathway by phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Activated KIT also transmits signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3, STAT5A and STAT5B. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KIT signaling is modulated by protein phosphatases, and by rapid internalization and degradation of the receptor. Activated KIT promotes phosphorylation of the protein phosphatases PTPN6/SHP-1 and PTPRU, and of the transcription factors STAT1, STAT3, STAT5A and STAT5B. Promotes phosphorylation of PIK3R1, CBL, CRK (isoform Crk-II), LYN, MAPK1/ERK2 and/or MAPK3/ERK1, PLCG1, SRC and SHC1.

Gene Wiki entry for KIT Gene

PharmGKB "VIP" Summary for KIT Gene

Additional gene information for KIT Gene

No data available for Tocris Summary , Rfam classification and piRNA Summary for KIT Gene

Genomics for KIT Gene

GeneHancer (GH) Regulatory Elements for KIT Gene

Promoters and enhancers for KIT Gene
GeneHancer (GH) Identifier GH Type GH
Score
GH Sources Gene Association Score Total Score TSS distance (kb) Number of Genes Away Size (kb) Transcription Factor
Binding Sites
Gene Targets
GH04J054658 Promoter/Enhancer 1.8 EPDnew Ensembl ENCODE CraniofacialAtlas 750.6 +1.1 1083 3.6 CTCF TCF7L2 L3MBTL2 NCOA6 GMEB1 GLIS2 ZIC2 RNF2 ARID2 REST KIT ENSG00000272969 CLOCK LOC105377657
GH04J054571 Enhancer 1.3 FANTOM5 Ensembl ENCODE 37.9 -86.2 -86217 2.2 ZBTB40 ZBTB6 SMARCE1 RUNX1 CC2D1A ELF1 L3MBTL2 DACH1 TEAD4 ZKSCAN8 KIT RN7SKP30 CHIC2 ENSG00000249706 ENSG00000272969 CLOCK HSALNG0034485 HSALNG0034479
GH04J054660 Promoter/Enhancer 1 FANTOM5 Ensembl ENCODE 31 +3.7 3740 1.6 PKNOX1 POLR2A FOS CEBPB JUND ZNF664 SMAD5 ZMYM3 KIT LOC105377657
GH04J054539 Promoter/Enhancer 1.2 FANTOM5 ENCODE CraniofacialAtlas 24.6 -118.2 -118177 0.8 EGR1 ZIC2 RXRA PRDM10 PKNOX1 HDAC1 ZBTB17 POLR2A RCOR1 ZFHX2 L13714-336 lnc-KIT-3 KIT piR-45012-369
GH04J054588 Enhancer 1.2 FANTOM5 Ensembl ENCODE 22.2 -69.4 -69388 0.7 SMARCE1 TCF7L2 L3MBTL2 DACH1 TEAD4 CBFA2T2 SMARCA4 ZNF639 TRIM24 MTA1 KIT HSALNG0034485 piR-43072
- Elite GeneHancer and/or Elite GeneHancer-gene association Download GeneHancer data from 2017 publication | Request up-to-date GeneHancer data (full dataset)

GeneHancers around KIT on UCSC Golden Path with GeneCards custom track

Top Transcription factor binding sites by QIAGEN in the KIT gene promoter:
  • AREB6
  • c-Myc
  • GCNF
  • GCNF-1
  • GCNF-2
  • Max1
  • MEF-2A
  • p53
  • RelA
  • STAT3

Genomic Locations for KIT Gene

Genomic Locations for KIT Gene
chr4:54,657,918-54,740,715
(GRCh38/hg38)
Size:
82,798 bases
Orientation:
Plus strand
chr4:55,524,085-55,606,881
(GRCh37/hg19)
Size:
82,797 bases
Orientation:
Plus strand

Genomic View for KIT Gene

Genes around KIT on UCSC Golden Path with GeneCards custom track

Cytogenetic band:
KIT Gene in genomic location: bands according to Ensembl, locations according to GeneLoc (and/or Entrez Gene and/or Ensembl if different)
Genomic Location for KIT Gene
GeneLoc Logo Genomic Neighborhood Exon StructureGene Density

RefSeq DNA sequence for KIT Gene

Proteins for KIT Gene

  • Protein details for KIT Gene (UniProtKB/Swiss-Prot)

    Protein Symbol:
    P10721-KIT_HUMAN
    Recommended name:
    Mast/stem cell growth factor receptor Kit
    Protein Accession:
    P10721
    Secondary Accessions:
    • B5A956
    • D5LXN2
    • D5M931
    • F5H8F8
    • Q6IQ28
    • Q99662
    • Q9UM99

    Protein attributes for KIT Gene

    Size:
    976 amino acids
    Molecular mass:
    109865 Da
    Quaternary structure:
    • Monomer in the absence of bound KITLG/SCF. Homodimer in the presence of bound KITLG/SCF, forming a heterotetramer with two KITLG/SCF molecules. Interacts (via phosphorylated tyrosine residues) with the adapter proteins GRB2 and GRB7 (via SH2 domain), and SH2B2/APS. Interacts (via C-terminus) with MPDZ (via the tenth PDZ domain). Interacts (via phosphorylated tyrosine residues) with PIK3R1 and PIK3 catalytic subunit. Interacts (via phosphorylated tyrosine) with CRK (isoform Crk-II), FYN, SHC1 and MATK/CHK (via SH2 domain). Interacts with LYN and FES/FPS. Interacts (via phosphorylated tyrosine residues) with the protein phosphatases PTPN6/SHP-1 (via SH2 domain), PTPN11/SHP-2 (via SH2 domain) and PTPRU. Interacts with PLCG1. Interacts with DOK1 and TEC. Interacts (KITLG/SCF-bound) with IL1RL1. Interacts with IL1RAP (independent of stimulation with KITLG/SCF). A mast cell-specific KITLG/SCF-induced interleukin-33 signaling complex contains IL1RL1, IL1RAP, KIT and MYD88.
    Miscellaneous:
    • Numerous proteins are phosphorylated in response to KIT signaling, but it is not evident to determine which are directly phosphorylated by KIT under in vivo conditions.

    Three dimensional structures from OCA and Proteopedia for KIT Gene

    Alternative splice isoforms for KIT Gene

    UniProtKB/Swiss-Prot:

neXtProt entry for KIT Gene

Selected DME Specific Peptides for KIT Gene

P10721:
  • EGGTYTF
  • ALYKNLL
  • TDKWEDYPKS
  • SIYVFVRDP
  • EDDELALD
  • RDLAARN
  • VAVKMLK
  • IDPTQLPY
  • LPVKWMA
  • DPGFVKWTFE
  • KGNARLP
  • LVRCPLTDPEVTNYSL
  • NIVNLLGACT
  • SDVWSYGI
  • VSYVVPTK
  • ALMSELK
  • CVYTFESDVWSYGI
  • YKYLQKP
  • KICDFGLARD
  • HIYSNLANC
  • KWMAPESIF
  • SPEHAPAEMYD
  • FSLGSSPYPGMPVDSKFYKMIKEG
  • EYCCYGDLLN
  • NEYMDMKPGVSY
  • AGFPEPT
  • NGMLQCV
  • GAFGKVVEATA
  • HNGTVEC
  • QWIYMNRT
  • GFPEPTIDWYFC
  • PVKWMAPE
  • YHRLCLHCS
  • GGPTLVITEYCC
  • MCIIVMIL
  • DFGLARDI
  • DYPKSENESNIRYV
  • WYFCPGTEQRC
  • IKDVSSSV
  • MKTCWDADPLKRPTFKQ

Post-translational modifications for KIT Gene

  • Ubiquitinated by SOCS6. KIT is rapidly ubiquitinated after autophosphorylation induced by KITLG/SCF binding, leading to internalization and degradation.
  • Autophosphorylated on tyrosine residues. KITLG/SCF binding enhances autophosphorylation. Isoform 1 shows low levels of tyrosine phosphorylation in the absence of added KITLG/SCF (in vitro). Kinase activity is down-regulated by phosphorylation on serine residues by protein kinase C family members. Phosphorylation at Tyr-568 is required for interaction with PTPN11/SHP-2, CRK (isoform Crk-II) and members of the SRC tyrosine-protein kinase family. Phosphorylation at Tyr-570 is required for interaction with PTPN6/SHP-1. Phosphorylation at Tyr-703, Tyr-823 and Tyr-936 is important for interaction with GRB2. Phosphorylation at Tyr-721 is important for interaction with PIK3R1. Phosphorylation at Tyr-823 and Tyr-936 is important for interaction with GRB7.
  • Glycosylation at Asn130, Asn145, Asn283, Asn293, Asn300, Asn320, Asn352, Asn367, Asn463, and Asn486
  • Modification sites at PhosphoSitePlus
  • Glycosylation from GlyConnect

Antibody Products

  • Abcam antibodies for KIT

Protein Products

  • Abcam proteins for KIT

Domains & Families for KIT Gene

Gene Families for KIT Gene

HGNC:
IUPHAR :
Human Protein Atlas (HPA):
  • Cancer-related genes
  • CD markers
  • Disease related genes
  • Enzymes
  • FDA approved drug targets
  • Plasma proteins
  • Predicted membrane proteins

Suggested Antigen Peptide Sequences for KIT Gene

GenScript: Design optimal peptide antigens:
  • Soluble KIT variant 1 (B5A956_HUMAN)
  • V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene-like protein (B6DXN3_HUMAN)
  • V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene-like protein (B6E0M6_HUMAN)
  • V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene-like protein transcript variant 2 (D5LXN2_HUMAN)
  • V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene-like protein transcript variant 2 (D5M931_HUMAN)

Graphical View of Domain Structure for InterPro Entry

P10721

UniProtKB/Swiss-Prot:

KIT_HUMAN :
  • Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
Family:
  • Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
genes like me logo Genes that share domains with KIT: view

Function for KIT Gene

Molecular function for KIT Gene

UniProtKB/Swiss-Prot Function:
Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. In response to KITLG/SCF binding, KIT can activate several signaling pathways. Phosphorylates PIK3R1, PLCG1, SH2B2/APS and CBL. Activates the AKT1 signaling pathway by phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Activated KIT also transmits signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3, STAT5A and STAT5B. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KIT signaling is modulated by protein phosphatases, and by rapid internalization and degradation of the receptor. Activated KIT promotes phosphorylation of the protein phosphatases PTPN6/SHP-1 and PTPRU, and of the transcription factors STAT1, STAT3, STAT5A and STAT5B. Promotes phosphorylation of PIK3R1, CBL, CRK (isoform Crk-II), LYN, MAPK1/ERK2 and/or MAPK3/ERK1, PLCG1, SRC and SHC1.
UniProtKB/Swiss-Prot CatalyticActivity:
Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-[protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1; Evidence={ECO:0000255 PROSITE-ProRule:PRU10028, ECO:0000269 PubMed:17662946, ECO:0000269 PubMed:19164557, ECO:0000269 PubMed:21640708, ECO:0000269 PubMed:2448137};.
UniProtKB/Swiss-Prot EnzymeRegulation:
Present in an inactive conformation in the absence of bound ligand. KITLG/SCF binding leads to dimerization and activation by autophosphorylation on tyrosine residues. Activity is down-regulated by PRKCA-mediated phosphorylation on serine residues. Inhibited by imatinib/STI-571 (Gleevec) and sunitinib; these compounds maintain the kinase in an inactive conformation.
UniProtKB/Swiss-Prot Induction:
Up-regulated by cis-retinoic acid in neuroblastoma cell lines.
GENATLAS Biochemistry:
Hardy-Zuckerman 4 feline sarcoma viral (v-kit or c-kit) oncogene homolog,homologous to murine dominant spotting,involved in melanogenesis

Enzyme Numbers (IUBMB) for KIT Gene

Phenotypes From GWAS Catalog for KIT Gene

Gene Ontology (GO) - Molecular Function for KIT Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0000166 nucleotide binding IEA --
GO:0002020 protease binding IEA --
GO:0004672 protein kinase activity IEA --
GO:0004713 protein tyrosine kinase activity TAS 1717985
GO:0004714 transmembrane receptor protein tyrosine kinase activity IDA,IBA 21640708
genes like me logo Genes that share ontologies with KIT: view

Phenotypes for KIT Gene

MGI mutant phenotypes for KIT:
inferred from 112 alleles
GenomeRNAi human phenotypes for KIT:
genes like me logo Genes that share phenotypes with KIT: view

Human Phenotype Ontology for KIT Gene

HPO Id HPO Name Alternative Ids Definition Synonyms

Animal Models for KIT Gene

MGI Knock Outs for KIT:
  • Kit Kit<tm1.1(cre)Jmol>
  • Kit Kit<tm2.1(cre/Esr1*)Jmol>
  • Kit Kit<tm1Alf>
  • Kit Kit<tm1Rosay>
  • Kit Kit<tm1.1Sraf>

Animal Model Products

CRISPR Products

Inhibitory RNA Products

  • Search GeneCopoeia for shRNA, lentivirus and/or AAV clone products for KIT

Clone Products

  • Addgene plasmids for KIT

No data available for Transcription Factor Targets and HOMER Transcription for KIT Gene

Localization for KIT Gene

Subcellular locations from UniProtKB/Swiss-Prot for KIT Gene

Isoform 1: Cell membrane; Single-pass type I membrane protein.
Isoform 2: Cell membrane; Single-pass type I membrane protein.
Isoform 3: Cytoplasm. Note=Detected in the cytoplasm of spermatozoa, especially in the equatorial and subacrosomal region of the sperm head.

Subcellular locations from

COMPARTMENTS
Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
COMPARTMENTS Subcellular localization image for KIT gene
Compartment Confidence
plasma membrane 5
extracellular 5
cytoskeleton 3
lysosome 3
mitochondrion 2
nucleus 2
endoplasmic reticulum 2
cytosol 2
golgi apparatus 1
peroxisome 0

Subcellular locations from the

Human Protein Atlas (HPA)
  • Plasma membrane (3)
See all subcellular structures

Gene Ontology (GO) - Cellular Components for KIT Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0001669 acrosomal vesicle IEA --
GO:0005615 extracellular space IDA 14625290
GO:0005737 cytoplasm IEA --
GO:0005886 plasma membrane TAS --
GO:0005887 integral component of plasma membrane IBA 21873635
genes like me logo Genes that share ontologies with KIT: view

Pathways & Interactions for KIT Gene

PathCards logo

SuperPathways for KIT Gene

SuperPathway Contained pathways
1 RET signaling
2 Apoptotic Pathways in Synovial Fibroblasts
.85
.85
.84
.84
.74
.72
.66
.65
.62
.61
.60
.57
3 GPCR Pathway
.73
.73
.62
.59
.58
.58
.55
.38
4 PI3K/AKT activation
5 ERK Signaling
.61
.61
.58
.51
.49
genes like me logo Genes that share pathways with KIT: view

SIGNOR curated interactions for KIT Gene

Activates:
Is activated by:
Is inactivated by:

Gene Ontology (GO) - Biological Process for KIT Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0000165 MAPK cascade TAS --
GO:0000187 activation of MAPK activity IDA 21640708
GO:0001541 ovarian follicle development ISS --
GO:0002244 hematopoietic progenitor cell differentiation IBA 21873635
GO:0002318 myeloid progenitor cell differentiation IEA --
genes like me logo Genes that share ontologies with KIT: view

Drugs & Compounds for KIT Gene

(117) Drugs for KIT Gene - From: DrugBank, PharmGKB, ClinicalTrials, ApexBio, DGIdb, IUPHAR, HMDB, and Novoseek

Name Status Disease Links Group Role Mechanism of Action Clinical Trials
Sunitinib Approved, Investigational Pharma Target, inhibitor VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor, RTK inhibitor, Potent VEGFR, PDGFRbeta and KIT inhibitor, Kinase Inhibitors, Vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) inhibitors 540
Dasatinib Approved, Investigational Pharma Target, antagonist, Inhibition, inhibitor Kinase Inhibitors, SRC/BCR-ABL tyrosine kinase inhibitors 312
imatinib Approved Pharma Target, antagonist, multitarget, inhibitor Kinase Inhibitors, SRC/BCR-ABL tyrosine kinase inhibitors 0
Sorafenib Approved, Investigational Pharma Target, antagonist, inhibitors, inhibitor Raf kinases and tyrosine kinases inhibitor, RAF, VEGFR2, and PDGFR-beta inhibitors, Kinase Inhibitors, Vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) inhibitors 762
midostaurin Approved, Investigational Pharma Target, antagonist, inhibitor Kinase Inhibitors 43

(41) Additional Compounds for KIT Gene - From: HMDB and Novoseek

Name Synonyms Role CAS Number PubChem IDs PubMed IDs
ADP
  • 5'-Adenylphosphoric acid
  • Adenosine 5'-diphosphate
  • ADENOSINE-5'-diphosphATE
  • H3ADP
  • 5'-Adenylphosphate
Full agonist, Agonist, Partial agonist, Antagonist, Gating inhibitor 58-64-0
N-desmethylimatinib
  • CGP74588

(32) ApexBio Compounds for KIT Gene

Compound Action Cas Number
Amuvatinib (MP-470, HPK 56) Tyrosine kinase inhibitor 850879-09-3
Apatinib VEGFR2 inhibitor, orally bioavailable, selective 811803-05-1
Axitinib (AG 013736) VEGFR1/ c-Kit inhibitor 319460-85-0
AZD2932 inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit 883986-34-3
Cabozantinib (XL184, BMS-907351) VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor 849217-68-1
DCC-2618 C-Kit/PDGFR inhibtor 1225278-16-9
Dovitinib (TKI-258, CHIR-258) Multitargeted RTK inhibitor 405169-16-6
Dovitinib Dilactic acid 852433-84-2
Imatinib (STI571) Protein-tyrosine kinase inhibitor 152459-95-5
Imatinib hydrochloride V-Abl/c-Kit/PDGFR inhibitor 862366-25-4
Imatinib Mesylate (STI571) Abl/c-kit/PDGFR inhibitor 220127-57-1
Linifanib (ABT-869) VEGFR/PDGFR inhibitor 796967-16-3
Masitinib (AB1010) Tyrosine kinase inhibitor, potent and selective 790299-79-5
Motesanib Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit 453562-69-1
Motesanib Diphosphate (AMG-706) VEGFR/ PDGFR/c-Kit/Ret inhibitor 857876-30-3
N-Desethyl Sunitinib VEGFR/PDGFRβ/KIT inhibitor 356068-97-8
OSI-930 Inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck 728033-96-3
Pazopanib (GW-786034) VEGFR/PDGFR/FGFR inhibitor 635702-64-6
Pazopanib Hydrochloride VEGFR/PDGFR/FGFR/c-Kit/ c-Fms inhibitor 635702-64-6
Regorafenib Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1 755037-03-7
SU14813 Tyrosine kinase inhibitor 627908-92-3
SU14813 double bond Z Tyrosine kinase inhibitor 452105-23-6
SU14813 maleate VEGFR/PDGFR/Kit/FLT-3 inhibitor 849643-15-8
SU5416 VEGF receptor inhibitor and AHR agonist 204005-46-9
Sunitinib RTK inhibitor 557795-19-4
Sunitinib malate VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor 341031-54-7
Telatinib (BAY 57-9352) VEGFR-2/-3,PDGFR-β and c-Kit inhibitor 332012-40-5
TG 100801 Multi-kinase inhibitor 867331-82-6
TG 100801 Hydrochloride VEGFr2 inhibitor 1018069-81-2
Toceranib c-Kit/VEGFR/PDGFR inhibtor 356068-94-5
Toceranib phosphate c-Kit/VEGFR/PDGFR inhibtor 874819-74-6
Vatalanib (PTK787) 2HCl Tyrosine kinase receptor inhibitor 212141-51-0
genes like me logo Genes that share compounds with KIT: view

Drug Products

Transcripts for KIT Gene

mRNA/cDNA for KIT Gene

CRISPR Products

Inhibitory RNA Products

  • Search GeneCopoeia for shRNA, lentivirus and/or AAV clone products for KIT

Clone Products

  • Addgene plasmids for KIT

Alternative Splicing Database (ASD) splice patterns (SP) for KIT Gene

ExUns: 1 ^ 2a · 2b ^ 3 ^ 4a · 4b ^ 5 ^ 6 ^ 7 ^ 8a · 8b ^ 9a · 9b ^ 10 ^ 11a · 11b ^ 12 ^ 13a · 13b ^ 14a · 14b ^ 15 ^ 16a · 16b ^ 17a · 17b ^
SP1: - - -
SP2: -
SP3:
SP4: -
SP5:
SP6:

ExUns: 18 ^ 19 ^ 20 ^ 21
SP1:
SP2:
SP3:
SP4:
SP5:
SP6:

Relevant External Links for KIT Gene

GeneLoc Exon Structure for
KIT
ECgene alternative splicing isoforms for
KIT

Expression for KIT Gene

mRNA expression in normal human tissues from GTEx, Illumina, BioGPS, and CGAP SAGE for KIT Gene

mRNA expression in embryonic tissues and stem cells from LifeMap Discovery